Cargando…
Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway
Bone cancer is one of the most common tumor types that occurs in bones and their affiliated tissues. The prognosis remains poor due to the limited number of effective therapeutic targets. Downregulation of bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) has been observed in h...
Autores principales: | Liu, Fengsong, Wang, Kai, Zhang, Liang, Yang, Ya-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144885/ https://www.ncbi.nlm.nih.gov/pubmed/30250579 http://dx.doi.org/10.3892/ol.2018.9268 |
Ejemplares similares
-
Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor
por: Liu, Yuhang, et al.
Publicado: (2021) -
Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling
por: Xie, Chen, et al.
Publicado: (2020) -
Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors
por: Breen, Michael J., et al.
Publicado: (2013) -
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
por: Ganjoo, Shonik, et al.
Publicado: (2022) -
Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-β/epithelial-mesenchymal transition signaling pathway
por: Yuan, Chun-Ling, et al.
Publicado: (2018)